Literature DB >> 17485247

Coenzyme Q treatment of neurodegenerative diseases of aging.

Wendy R Galpern1, Merit E Cudkowicz.   

Abstract

The etiology of several neurodegenerative disorders is thought to involve impaired mitochondrial function and oxidative stress. Coenzyme Q-10 (CoQ10) acts both as an antioxidant and as an electron acceptor at the level of the mitochondria. In several animal models of neurodegenerative diseases including amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease, CoQ10 has shown beneficial effects. Based on its biochemical properties and the effects in animal models, several clinical trials evaluating CoQ10 have been undertaken in many neurodegenerative diseases. CoQ10 appears to be safe and well tolerated, and several efficacy trials are planned.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485247     DOI: 10.1016/j.mito.2007.01.004

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  18 in total

Review 1.  Drug development for rare mitochondrial disorders.

Authors:  Orest Hurko
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

2.  4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures.

Authors:  Ulrika Forsman; Mats Sjöberg; Mikael Turunen; Pavel J Sindelar
Journal:  Nat Chem Biol       Date:  2010-06-06       Impact factor: 15.040

3.  Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients.

Authors:  Gaetano Gorgone; Monica Currò; Nadia Ferlazzo; Giulia Parisi; Lucilla Parnetti; Vincenzo Belcastro; Nicola Tambasco; Aroldo Rossi; Francesco Pisani; Paolo Calabresi; Riccardo Ientile; Daniela Caccamo
Journal:  Neuromolecular Med       Date:  2012-02-22       Impact factor: 3.843

4.  Decylubiquinone increases mitochondrial function in synaptosomes.

Authors:  Jayne E Telford; Seán M Kilbride; Gavin P Davey
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

5.  Coenzyme Q10: is there a clinical role and a case for measurement?

Authors:  Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

6.  Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2.

Authors:  Ryoichi Saiki; Adam L Lunceford; Yuchen Shi; Beth Marbois; Rhonda King; Justin Pachuski; Makoto Kawamukai; David L Gasser; Catherine F Clarke
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10

7.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 8.  Nutrition and dietary supplements in motor neuron disease.

Authors:  Jeffrey Rosenfeld; Amy Ellis
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

9.  The yeast Coq4 polypeptide organizes a mitochondrial protein complex essential for coenzyme Q biosynthesis.

Authors:  Beth Marbois; Peter Gin; Melissa Gulmezian; Catherine F Clarke
Journal:  Biochim Biophys Acta       Date:  2008-10-31

10.  Altered bacterial metabolism, not coenzyme Q content, is responsible for the lifespan extension in Caenorhabditis elegans fed an Escherichia coli diet lacking coenzyme Q.

Authors:  Ryoichi Saiki; Adam L Lunceford; Tarra Bixler; Peter Dang; Wendy Lee; Satoru Furukawa; Pamela L Larsen; Catherine F Clarke
Journal:  Aging Cell       Date:  2008-02-11       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.